Calysta is reviving the production of proven methane to feed technology BioProtein – a fishmeal alternative for use in aquaculture and animal nutrition that has hit several bumps along the road to market.
Calysta, a US developer of natural gas conversion technology using methane for fuel and chemicals, bought Norway based, BioProtein A/S, in May last year.
“The primary driver for acquiring BioProtein was to merge our expertise in fermentation biology with a commercial scale fermenter. BioProtein had a lot going for it, including an EU product registration for microbial protein that was specific to its process, strong customer relationships with salmon feed producers in Norway, and an IP portfolio that StatOil spent years developing.
We are actively developing an 80,000 ton per year production plant in Europe. We expect commercial volumes to be available beginning Q4 2017,” Alan Shaw, CEO of Calysta, told FeedNavigator.
The feed generated is a proteinrich biomass produced by a microbial culture with natural gas as sole nutrition and energy source.
[Source:Jane Byrne, Feed Navigator. Read Article]
